Cynata signs LOIs regarding MSCs
21 December, 2015It's been a busy month for Cynata Therapeutics, with the company signing two letters of intent regarding the licensing and development of its proprietary MSC technology, Cymerus.
Pharma R&D returns continue to decline
17 December, 2015The projected rate of return on pharmaceutical R&D has more than halved since 2010, from 10.1% to 4.2%, according to an annual study by the Deloitte Centre for Health Solutions.
Paediatric CF trial reports positive results
17 December, 2015Pharmaxis has announced positive results for its recently completed Phase II trial of Bronchitol, a precision spray-dried form of mannitol, in children and adolescents with cystic fibrosis (CF).
GSK to pilot new vaccine manufacturing method
16 December, 2015GSK Australia's new pilot facility will use an innovative manufacturing method to produce vaccines on a commercial scale.
Web platform to help drug discovery efforts
08 December, 2015The Centre for Therapeutic Target Validation has launched the Target Validation Platform — a web-based platform that helps life science researchers identify therapeutic targets for new and repurposed medicines.
Anxiety drug could treat PTSD
08 December, 2015Bionomics is set to launch a phase 2 trial of its novel anxiety drug BNC210 as a treatment for post-traumatic stress disorder (PTSD).
Biotech expert appointed to CSIRO board
07 December, 2015Professor Edwina Cornish AO, provost and senior vice-president of Monash University, has been appointed as a member of the CSIRO board for five years.
Drug discovery partnership to focus on cancer treatment
01 December, 2015Yabao Pharmaceutical and the University of South Australia have formalised their agreement to collaborate on the development and commercialisation of innovative new pharmaceuticals.
WA to trial genetically modified medflies
26 November, 2015 by Graeme O'NeillWestern Australia announced this week that it will trial a novel GM sterile-insect technology that could rid the state of the Mediterranean fruit fly...
Improving implants with primordial goo
25 November, 2015CSIRO has used molecules from primordial goo to develop a coating that could be used to improve medical devices and implants.
Emerson and GE Healthcare collaborate on biopharma manufacturing
20 November, 2015GE Healthcare's Life Sciences business and Emerson Process Management have announced a collaboration aimed at increasing productivity and improving efficiency in the production of biopharmaceuticals such as monoclonal antibodies and vaccines.
Invion aims for Phase 3 smoking cessation trial
17 November, 2015Invion claims that the results from its Phase 2 clinical trial of INV102 (nadolol) in patients trying to quit smoking warrant progression to a Phase 3 trial.
Two drug discovery initiatives for UniQuest
11 November, 2015The commercialisation company of The University of Queensland, UniQuest, will be part of two separate drug discovery initiatives.
Invion's share purchase plan and asthma trial
10 November, 2015Invion has opened a share purchase plan (SPP), allowing eligible shareholders to purchase up to $15,000 worth of shares at a discount and without any brokerage or transaction costs.
A heart failure drug that reduces scar tissue
09 November, 2015Drug development company Armaron Bio has begun its Phase II clinical trial for NP202, its lead candidate drug for heart failure.
